CAC 0 takes a gut punch, ICD therapies cannot...
John Mandrola discusses conduction system pac...
Big new hypertension guidelines, ultraprocess...
Listener feedback on SURPASS CVOT, AF ablatio...
Exercise and CV outcomes, aldosterone modulat...
The VENTOUX study of endurance athletes, the ...
Finerenone, what not to consider when choosin...
Approval of first-generation devices, the tic...
FDA approves triple-drug polypill, a change o...
A big, deep dive into CTA and fractional flow...